Study on the Mechanism of Üstikuddus Sherbiti in Ischemic Cerebrovascular Diseases: Based on Network Pharmacology

Figure 13

The conformations of some important compounds and key targets. Compound-target interactions with binding energy less than −5.0 kcal/mol are shown: (a) PIK3CA with kaempferol, (b) PIK3RI with quercetin, (c) AKT1 with luteolin, (d) AKT1I with quercetin, (e) MAPK1 with luteolin, (f) mTOR with kaempferol, (g) MEK1 with quercetin, (h) MEK2 with kaempferol, (i) NF-κB1 with quercetin, and (j) IKKβ with quercetin.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)